Global Cancer Tumor Profiling Market Forecast To Reach $22.06 Billion By 2028 With 14.3% Annual Growth

The Business Research Company’s Early Year-End Sale! Get up to 30% off detailed market research reports—for a limited time only!

LONDON, GREATER LONDON, UNITED KINGDOM, November 22, 2024 /EINPresswire.com/ -- The Business Research Company’s Early Year-End Sale! Get up to 30% off detailed market research reports—limited time only!

The cancer tumor profiling market has seen significant growth, projected to rise from $11.17 billion in 2023 to $12.93 billion in 2024, with a compound annual growth rate (CAGR) of 15.7%. This growth has been fueled by rising cancer incidence, advancements in precision medicine and research collaborations, improvements in cancer diagnostics and early detection, a broad range of targeted therapy options, and supportive regulatory frameworks for cancer profiling tests.

What Are the Market Size Estimates for the Global Cancer Tumor Profiling Market and Its Expected Growth Rate?
The cancer tumor profiling market is projected to grow rapidly, reaching $22.06 billion by 2028 with a CAGR of 14.3%. This growth is fueled by the expansion of immunotherapy and immune profiling in cancer care, advancements in liquid biopsy and non-invasive profiling methods, adoption of single-cell sequencing for enhanced tumor characterization, increased cancer screening and early detection efforts, and rising demand for profiling rare and orphan cancer subtypes. Key trends include the integration of tumor profiling into clinical practice, progress in multi-omics approaches, the use of AI and machine learning in data analysis, advancements in personalized medicine and targeted therapies, and innovations in genomics and next-generation sequencing technologies.

Access a Comprehensive Sample Report for Exclusive Insights Into the Global Cancer Tumor Profiling Market:
https://www.thebusinessresearchcompany.com/sample_request?id=6053&type=smp

What Are The Primary Growth Drivers Of The Cancer Tumor Profiling Market?
The rising global incidence of cancer is anticipated to fuel growth in the cancer and tumor profiling market. Cancer occurs when certain body cells grow uncontrollably and spread to other areas. As cancer cases increase, the demand for tumor profiling also rises, helping doctors assess disease severity more accurately.

Pre-book the report for a swift delivery:
https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report

Who Are The Top Market Players Contributing To The Growth Of The Cancer Tumor Profiling Market?
Key players in the market include F. Hoffmann-La Roche Ltd., Caris Life Sciences, Thermo Fisher Scientific Inc., Illumina Inc., Qiagen, Ribomed Biotechnologies Inc., HTG Molecular Diagnostics Inc., NanoString Technologies Inc., NeoGenomics Laboratories Inc., Lucence Health Inc., ACT Genomics Co. LTD, Strand Life Sciences, IMB Dx Inc., Exact Sciences Corporation, Guardant Health, Foundation Medicine Inc.

What Emerging Trends Are Affecting The Size Of The Cancer Tumor Profiling Market?
A key trend gaining momentum in the cancer and tumor profiling market is the rise in research and development activities. Leading companies in this sector are prioritizing R&D efforts to meet consumer demand and strengthen their market standing.

How Is the Global Cancer Tumor Profiling Market Segmented?
1) By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Ovarian Cancer, Stomach Cancer, Pancreatic Cancer, Thyroid Cancer, Other Cancer Types
2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ Hybridization (ISH), Microarray, Other Technologies
3) By Process Type: Genomics, Proteomics, Epigenetics, Metabolomics, Other Types
4) By Application: Personalized Medicine, Diagnostics, Biomarker Discovery, Prognostics, Research Applications

Geographical Analysis: North America Emerges as the Cancer Tumor Profiling Market Leader
North America was the largest region in cancer and tumor profiling market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer tumor profiling market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Is The Definition And Overview Of The Cancer Tumor Profiling Market?
Cancer tumor profiling is a lab test that analyzes a tumor tissue sample for specific genes, mutations, proteins, or other biomarkers. This profiling aids in treatment planning and helps predict if cancer may recur or spread to other areas of the body.

The Cancer Tumor Profiling Global Market Report 2024 from The Business Research Company includes the following key information:
• Market size data for both historical and future periods
• Analysis of both macro and microeconomic factors that have impacted the market over the past five years
• Regional market analysis covering Asia-Pacific, China, Western Europe, Eastern Europe, North America, the USA, South America, and the Middle East and Africa
• Country-specific market analysis for Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA.

Overview of the Global Cancer Tumor Profiling Market Report: Trends, Opportunities, Strategies, and More
The Cancer Tumor Profiling Global Market Report 2024 from The Business Research Company is an extensive resource that delivers insights into cancer tumor profiling market size, cancer tumor profiling market drivers and trends, cancer tumor profiling global market major players, cancer tumor profiling competitors' revenues, cancer tumor profiling global market positioning, and cancer tumor profiling market growth across geographies. This report provides valuable in-depth insights into potential opportunities and strategies. Companies can utilize the information presented to target segments with the greatest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Cancer biologics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report
Tumor Ablation Therapy Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/tumor-ablation-therapy-devices-global-market-report
Tumor Embolization Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report

What Services Does The Business Research Company Offer?
The Business Research Company has published more than 15,000 reports spanning 27 industries and over 60 regions. Our research is supported by 1.5 million datasets, thorough secondary research, and unique insights gained from interviews with industry experts. We offer ongoing and customized research services, featuring a variety of specialized packages designed to meet your specific needs, such as Market Entry Research, Competitor Tracking, Supplier & Distributor Packages, and many others.
Our flagship product, the Global Market Model, serves as a leading market intelligence platform that provides comprehensive and updated forecasts to facilitate informed decision-making.

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:
Facebook
X
LinkedIn